Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase enzymes (MAPKs) are central serine/threonine protein kinases in eukaryotic cells that regulate the transduction of extracellular signals into cellular responses. The classical MAPKs (ERK, JNK, and p38 kinases) function as part of three-tiered phosphorylation cascades, modulating processes including growth, proliferation, differentiation, survival, apoptosis, immune response, and stress adaptation. These enzymes respond to diverse signals (growth factors, cytokines, stress stimuli) and are implicated in the pathogenesis of cancer, inflammatory diseases, and other disorders. MAPK pathway enzymes are therapeutic targets for multiple small-molecule inhibitors, especially in cancer therapy, although they present challenges including resistance and toxicity.
Inhibition of phosphorylation activity (blocks kinase cascade) Disruption of downstream signaling (blocks cell proliferation, induces apoptosis) Interference with substrate binding and activation loop phosphorylation Modulation of gene expression via transcription factor regulation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase enzyme (MAPK) (MAPK).